Showing results (141-150 of 153) with videos related to
Sort By:
Pageof 16
Cancer Discovery|May 22, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaLipika Goyal, Lei Shi, Leah Y Liu, et al.Nature Reviews. Clinical Oncology|July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaperArvind Dasari, Van K Morris, Carmen J Allegra, et al.Cancer Discovery|April 30, 2021
<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.Nature Medicine|January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trialJun Tian, Jonathan H Chen, Sherry X Chao, et al.Nature Medicine|November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.Nature Medicine|September 11, 2019
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancersAparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.Cancer Discovery|March 23, 2022
Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal CancerMihir Rajurkar, Aparna R Parikh, Alexander Solovyov, et al.Biorxiv : the Preprint Server for Biology|February 7, 2023
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarkerMartin S Taylor, Wu Connie, Peter C Fridy, et al.Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.Pageof 16